Splenectomy outcomes in patients with autoimmune cytopenias and persistent antiphospholipid antibodies.

Juan Rangel-PatiñoAna Barrera-VargasSamuel Govea-PelaézJavier Merayo-ChalicoDaniela Pérez-SámanoOmar Vargas-SerafínRoberta Demichelis-Gómez

Published in: Transfusion (2022)

Splenectomy for treatment-refractory autoimmune cytopenia's patients with persistent aPL is an effective treatment despite some safety concerns related to early infections. These results suggest that the presence of aPL should not impact the decision to undergo splenectomy.

Keyphrases

multiple sclerosis
type diabetes
metabolic syndrome
adipose tissue
combination therapy
decision making
glycemic control